Form 4 for OPCH Option Care Health, Inc.
Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001437749-23-004597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-24 | 2023-02-22 | OPCH | RADEMACHER JOHN CHARLES | CEO, Dir | A - Grant | $0.00 | +210.9K | 279.8K | +306% | $0 | |
| 2023-02-24 | 2023-02-23 | OPCH | RADEMACHER JOHN CHARLES | CEO, Dir | F - Tax | $31.90 | -11.7K | 268.1K | -4% | -$372.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-22 | A | A | 210,864 | $0.00 | 279,753 | D | — | — | (F1) Represents shares of common stock issuable under a performance-based restricted stock unit award dated February 23, 2021. On February 22, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest on February 23, 2024, assuming continuous service on the vesting date. |
| 2 | Common | Common Stock | 2023-02-23 | F | D | 11,679 | $31.90 | 268,074 | D | — | — |